Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Mog

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cancer Immunology Research|September 19, 2019
Direct Detection and Quantification of NeoantigensQing Wang, Jacqueline Douglass, Michael S Hwang, et al.
Nature Methods|April 6, 2023
Improving the sensitivity of in vivo CRISPR off-target detection with DISCOVER-SeqRoger S Zou, Yang Liu, Oscar E Reyes Gaido, et al.
Nature Biotechnology|May 4, 2021
Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strandsJoshua D Cohen, Christopher Douville, Jonathan C Dudley, et al.
Nature Cancer|October 22, 2021
Targeting public neoantigens for cancer immunotherapyAlexander H Pearlman, Michael S Hwang, Maximilian F Konig, et al.
Nature Cancer|February 5, 2022
Author Correction: Targeting public neoantigens for cancer immunotherapyAlexander H Pearlman, Michael S Hwang, Maximilian F Konig, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2021
Targeting loss of heterozygosity for cancer-specific immunotherapyMichael S Hwang, Brian J Mog, Jacqueline Douglass, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Engineering immunotoxin-equipped effector cells and evaluation in primary human immune cellsAlexander H Pearlman, Brian J Mog, Michael S Hwang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2026
Lethal toxin-equipped effector cells for the potential treatment of cancerAlexander H Pearlman, Brian J Mog, Michael S Hwang, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Spatial Regulation of CAR Signaling Enables Logic-Gated ActivityTushar D Nichakawade, Brian J Mog, Alexander H Pearlman, et al.
Science Translational Medicine|March 2, 2021
TCR β chain-directed bispecific antibodies for the treatment of T cell cancersSuman Paul, Alexander H Pearlman, Jacqueline Douglass, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cancer Immunology Research|September 19, 2019
Direct Detection and Quantification of NeoantigensQing Wang, Jacqueline Douglass, Michael S Hwang, et al.
Nature Methods|April 6, 2023
Improving the sensitivity of in vivo CRISPR off-target detection with DISCOVER-SeqRoger S Zou, Yang Liu, Oscar E Reyes Gaido, et al.
Nature Biotechnology|May 4, 2021
Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strandsJoshua D Cohen, Christopher Douville, Jonathan C Dudley, et al.
Nature Cancer|October 22, 2021
Targeting public neoantigens for cancer immunotherapyAlexander H Pearlman, Michael S Hwang, Maximilian F Konig, et al.
Nature Cancer|February 5, 2022
Author Correction: Targeting public neoantigens for cancer immunotherapyAlexander H Pearlman, Michael S Hwang, Maximilian F Konig, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2021
Targeting loss of heterozygosity for cancer-specific immunotherapyMichael S Hwang, Brian J Mog, Jacqueline Douglass, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Engineering immunotoxin-equipped effector cells and evaluation in primary human immune cellsAlexander H Pearlman, Brian J Mog, Michael S Hwang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2026
Lethal toxin-equipped effector cells for the potential treatment of cancerAlexander H Pearlman, Brian J Mog, Michael S Hwang, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Spatial Regulation of CAR Signaling Enables Logic-Gated ActivityTushar D Nichakawade, Brian J Mog, Alexander H Pearlman, et al.
Science Translational Medicine|March 2, 2021
TCR β chain-directed bispecific antibodies for the treatment of T cell cancersSuman Paul, Alexander H Pearlman, Jacqueline Douglass, et al.
Pageof 3